Type of medication | No. of patients | Gender | Age (years) | Indications for antiplatelet therapy | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
F | M | The youngest | The oldest | Mean | Primary prevention | Infarction | ACS | Stent implantation | Bypass | PCI | |||
ASA | n | 38 | 16 | 22 | 49.0 | 65.0 | 57.4 | 32 | 0 | 0 | 0 | 0 | 0 |
% | 24.8 | 22.5 | 26.8 | – | – | – | 100 | 0 | 0 | 0 | 0 | 0 | |
Clopidogrel | n | 41 | 26 | 15 | 55.0 | 67.0 | 59.8 | 0 | 14 | 11 | 10 | 9 | 3 |
% | 26.8 | 36.6 | 18.3 | – | – | – | 0 | 37.9 | 40.7 | 37.0 | 60.0 | 16.7 | |
DAPT* | n | 74 | 29 | 45 | 59.0 | 66.0 | 62.6 | 0 | 23 | 16 | 17 | 6 | 15 |
% | 48.4 | 40.8 | 54.9 | – | – | – | 0 | 62.1 | 59.3 | 63.0 | 40.0 | 83.3 | |
Total | n | 153 | 71 | 82 | 49.0 | 67.0 | 60.2 | 32 | 37 | 27 | 27 | 15 | 18 |
% | 100 | 100 | 100 | – | – | – | 100 | 100 | 100 | 100 | 100 | 100 |